Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for NWT Uranium Corp. (CPTRF : OTC)
 
 • Company Description   
Captor Capital Corp. is a vertically integrated cannabis company. It cultivates, manufacture and distribute recreational and medical marijuana based products to consumers through brands and dispensary retail stores. Captor Capital Corp., formerly known as NWT URANIUM CP, is based in Toronto, Canada.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $ Daily Weekly Monthly
20 Day Moving Average: shares
Shares Outstanding: 38.63 (millions)
Market Capitalization: $ (millions)
Beta:
52 Week High: $0.23
52 Week Low: $0.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week % %
12 Week % %
Year To Date % %
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
4 King Street West Suite 401
-
Toronto,A6 M5H 1B6
CAN
ph: 416-504-3978
fax: -
gavin@captorcapital.com http://www.captorcapital.com
 
 • General Corporate Information   
Officers
John Zorbas - Chief Executive Officer and President
Wayne Lipschitz - Chief Operating Officer
Jing Peng - Chief Financial Officer
Matt Longo - Director
Oliver Summers - Director

Peer Information
NWT Uranium Corp. (BJCT)
NWT Uranium Corp. (CADMQ)
NWT Uranium Corp. (APNO)
NWT Uranium Corp. (UPDC)
NWT Uranium Corp. (IMTIQ)
NWT Uranium Corp. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 14075H202
SIC: 1000
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 12/01/21
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 38.63
Most Recent Split Date: 10.00 (0.05:1)
Beta:
Market Capitalization: $ (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: %
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -200.00%
vs. Previous Quarter: -33.33%
Sales Growth
vs. Year Ago Period: 21.70%
vs. Previous Quarter: -0.83%
ROE
03/31/22 - -
12/31/21 - -24.14
09/30/21 - -13.63
ROA
03/31/22 - -
12/31/21 - -16.48
09/30/21 - -9.73
Current Ratio
03/31/22 - -
12/31/21 - 2.79
09/30/21 - 2.89
Quick Ratio
03/31/22 - -
12/31/21 - 2.60
09/30/21 - 2.71
Operating Margin
03/31/22 - -
12/31/21 - -38.72
09/30/21 - -22.92
Net Margin
03/31/22 - -
12/31/21 - -35.71
09/30/21 - -22.20
Pre-Tax Margin
03/31/22 - -
12/31/21 - -34.96
09/30/21 - -31.98
Book Value
03/31/22 - -
12/31/21 - 0.94
09/30/21 - 0.97
Inventory Turnover
03/31/22 - -
12/31/21 - 10.08
09/30/21 - 10.33
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.19
09/30/21 - 0.11
 

Powered by Zacks Investment Research ©